Define genetically/epigenetically modified targets in the immune niche of DLBCLs- Project 2 Grant

Overview

date/time interval

October 1, 2022 - September 30, 2027

awarded by

Leukemia & Lymphoma Society, Inc.

administered by

Medicine-Hematology and Medical Oncology

sponsor award ID

UHN 224060-01

Affiliation

contributor

Barisic, Darko Principal Investigator (Subaward) 2022 - 2027
Melnick, Ari M. Principal Investigator (Subaward) 2022 - 2027